# Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

> **NCT01730157** · EARLY_PHASE1 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Ciliary Body and Choroid Melanoma, Medium/Large Size
- Ciliary Body and Choroid Melanoma, Small Size
- Extraocular Extension Melanoma
- Iris Melanoma
- Liver Metastases
- Metastatic Intraocular Melanoma
- Recurrent Intraocular Melanoma
- Stage IV Intraocular Melanoma

## Interventions

- **BIOLOGICAL:** ipilimumab
- **RADIATION:** yttrium Y 90 glass microspheres
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01730157
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Research Cancelled
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730157, "Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01730157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*